Abstract
This article documents both the neurological and physical outcomes of the first published set of siblings undergoing transplantation at differing ages for α-mannosidosis. The older brother, the index case, was diagnosed at the age of 3 years and underwent transplantation at 13 years for the treatment of increasing somatic problems and recurrent infections. The younger brother had undergone transplantation pre-symptomatically at 6 months of age. Their clinical, radiological and developmental outcomes are documented and compared with the previous published cases, with the case for early transplantation being weighted against other potential therapies.
Similar content being viewed by others
Abbreviations
- ERT:
-
enzyme replacement therapy
- HCT:
-
haematopoietic cell transplantation
- HLA:
-
human leukocyte antigen
- MRI:
-
magnetic resonance imaging
- CT:
-
computed tomography
- MPS I:
-
mucopolysaccharidosis type 1
- CNS:
-
central nervous system
References
Abraham D, Muir H, Olsen I, Winchester B (1985) Direct enzyme transfer from lymphocytes corrects a lysosomal storage disease. Biochem Biophys Res Commun 129:417–425
Albert MH, Schuster F, Peters C et al (2003) T cell depleted peripheral blood stem cell transplantation for α-mannosidosis. Bone Marrow Transplant 32:443–446
Ara JR, Mayayo E, Marzo ME, Guelbenzu S, Chabis A, Pina MA, Calderon C (1999) Neurological impairment in α-mannosidosis: a longitudinal clinical and MRI study of a brother and sister. Childs Nerv Syst 15:369–371
Bahr BA, Bendiske J (2002) The neuropathogenic contributions of lysosomal dysfunction. J Neurochem 83:481–489
Berg T, Riise HM, Hansen GM, Malm D, Tranebbjarg L, Tollersrud OK (1999) Spectrum of mutations in alpha-mannosidosis. Am J Hum Genet 64:77–88
Blanz J, Stroobants S, Lullmann-Rauch R et al (2008) Reversal of peripheral and central neuronal storage and ataxia after recombinant enzyme replacement therapy in α-mannosidosis mice. Hum Mol Genet 17:3437–3445
Boelens JJ, Wynn RF, O’Meara A et al (2007) Outcomes of hematopoietic stem cell transplantation for Hurler’s syndrome in Europe: a risk factor analysis for graft failure. Bone Marrow Transplant 40:225–233
Chester MA, Lundblad A, Ockerman PA, Autio S (1982) Mannosidosis. In: Durand P, O’Brien JS (eds) Genetic errors in glycoprotein metabolism. Springer, Berlin, p 89
Clark GF, Patankar MS (1998) Response to a letter to Glyco-Forum entitled “Hypothesis: immunodeficiencies ina-mannosidosis, mycosis, AIDS and cancer—acommon mechanism of inhibition of the functionof the lectin interleukin 2 by oligomannosides”. Glycobiology 8:iii–iv
Crawley AC, Walkley SU (2007) Developmental analysis of CNS pathology in the lysosomal storage disease α-mannosidosis. J Neuropathol Exp Neurol 66:687–697
Dietmann JL, Flippi de la Palavesa MM, Tranchant C, Kastler B (1990) MR findings in mannosidosis. Neuroradiology 32:485–487, PMID 2287376
Dobrenis K (1992) Mechanisms underlying successful treatment of neuronal storage disease. Abstract 034 of the 7th International Congress of Inborn Errors of Metabolism, Vienna, Austria
Futerman AH, van Meer G (2004) The cell biology of lysosomal storage disorders. Nat Rev Mol Cell Biol 5:554–565
Grewal SS, Shapiro EG, Krivit W et al (2004) Effective treatment of α-mannosidosis by allogeneic haematopoietic stem cell transplantation. J Pediatr 144:569–573
Hansen MD, Filipovich AH, Davies SM et al (2008) Allogeneic hematopoietic cell transplantation (HCT) in Hurler’s syndrome using a reduced intensity preparative regimen. Bone Marrow Transplant 41:349–353
Hickey WF, Kimura H (1998) Perivascular microglial cells of the CNS are bone derived and present in vivo. Science 239:290–292
Hoffmann B, Keshav S (2007) Gastrointestinal symptoms in Fabry disease: everything is possible, including treatment. Acta Paediatr Suppl 96:84–86, PMID 17391450
Jeyakumar M, Dwek RA, Butters TD, Platt FM (2005) Storage solutions treating lysosomal disorders of the brain. Nat Rev Neurosci 6:713–725
Kakkis ED, Muenzer J, Tiller GE, Waber L et al (2001) Enzyme replacement therapy in mucopolysaccharidosis. N Eng J Med 344:1831–1888
Kennedy DW, Abkowitz JL (1997) Kinetics of central nervous system miroglial and macrophage engraftment: analysis using a transgenic bone marrow transplantation model. Blood 90:986–993
Kharbanda S, Panoskaltis-Moratari A, Haddad IY et al (2006) Inflammatory cytokines and the development of Pulmonary complications after allogeneic Hematopoietic Cell transplantation in patients with inherited metabolic storage disorders. Biol Blood Marrow Transplant 12:430–437
Knoll RB, Kulkarni R, Netzloff ML (1986) Follow up of language and cognitive development in patients with mannosidosis. Arch Neurol 43:157–159
Malm D, Pantel J, Linaker OM (2005) Psychiatric symptoms in alpha-mannosidosis. J Intellect Disabil Res 49:865–871
Miano M, Labopin M, Hartmann O et al (2007) Haematopoietic stem cell transplantation trends in children over the last three decades: a survey by the paediatric diseases working party of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 39:89–99
Michalski JC, Klein A (1999) Glycoprotein lysosomal storage disorders: α- and β-mannosidosis, fucosidosis and α-N-acetylgalactosaminidase deficiency. Biochem Biophys Acta 1455:69–84
Mitchell ML, Erickson RP, Schmid D, Hieber V, Poznanski AK, Hicks SP (1981) Mannosidosis: two brothers with different degrees of disease severity. Clin Genet 20:191–202
O’Brien T, Eastlund T, Peters C, Neglia JP, Defor T, Ramsay NKC, Baker KS (2004) Autoimmune haemolytic anaemia complicating haematopoietic cell transplantation in paediatric patients: high incidence and significant mortality in unrelated transplants for non-malignant diseases. Br J Haematol 127:67–75
Peters CJ (2003) Effective treatment of the central nervous system in lysosomal storage diseases: save that brain. J Lab Clin Med 142:361–363
Roces DP, Lüllmann-Rauch R, Peng J et al (2004) Efficacy of enzyme replacement therapy in α-mannosidosis mice: a preclinical animal study. Hum Mol Genet 13:1979–1988
Spranger J, Gehler J, Cantz M (1976) The radiographic features of α-mannosidosis. Radiology 119:401
Staba SL, Escolar ML, Poe M et al (2004) Cord-blood transplants from unrelated donors in patients with Hurler’s syndrome. N Engl J Med 350:1932–1934
Sun H, Wolfe JH (2001) Recent progress in lysosomal α-mannosidosis and its deficiency. Exp Mol Med 33:1–7
Thomas G (2001) Disorders of glycoprotein degradation: α-mannosidosis, β-mannosidosis, fucosidosis and sialidosis. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Childs B, Kinzler KW, Vogelstein B (eds) The metabolic and molecular bases of inherited metabolic disease, 8th edn. McGraw-Hill Medical, pp 3507–3516
Vite CH, McGowan JC, Niogi SN, Passini MA, Drobatz KJ, Haskins ME, Wolfe JH (2005) Effective gene therapy for an inherited metabolic disease in a large animal model. Ann Neurol 57:355–364
Walkley SU (2004) Pathogenic cascades and brain dysfunction. In: Platt FM, Walkley SU (eds) Lysosomal disorders of the brain. Oxford University Press, New York, p 290–324
Walkley SU (2007) Pathological mechanisms in lysosomal disease: a reappraisal of the role of the lysosome. Acta Paediatr 96:26–32
Walkley SU, Dobrenis K (1995) Bone marrow transplantation for the treatment of lysosomal storage disorders. Lancet 345:1398–1402
Acknowledgements
The authors thank Dr. Stensland, Senior Scientist, Department of Medical Genetics, University Hospital of Northern Norway, Breivika, Tromsø, Norway, for her work on the identification of the mutation in these patients.
Author information
Authors and Affiliations
Corresponding author
Additional information
Communicated by: Olaf Bodamer
Competing interest: None declared
Rights and permissions
About this article
Cite this article
Broomfield, A.A., Chakrapani, A. & Wraith, J.E. The effects of early and late bone marrow transplantation in siblings with alpha-mannosidosis. Is early haematopoietic cell transplantation the preferred treatment option?. J Inherit Metab Dis 33 (Suppl 3), 123–127 (2010). https://doi.org/10.1007/s10545-009-9035-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10545-009-9035-4